ArticleCancer chemotherapy and pharmacology2025

Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer.

Hayato Yokota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.